The objective of this study was to compare contralateral snare vs retrograde gate cannulation during endovascular aneurysm repair to determine the most efficient technique and to evaluate whether time was affected by graft design or the surgeon's experience. This is an Institutional Review Board-approved prospective randomized study involving single-center elective endovascular aneurysm repairs. Patients were randomized to snare or retrograde in a 1:1 ratio. The initial method was attempted for 15 minutes; if it was unsuccessful, the team switched to the alternative technique for an additional 15 minutes. The protocol continued until success was achieved. Data collected on demographic, anatomic, and procedural factors were analyzed for statistically significant differences. A total of 101 patients were included. Average age was 75.3 years, and 82% were male. Forty-nine patients were randomized to snare and 52 to retrograde. The groups were overall similar (Table I). Mean cannulation times were 3.9 minutes for snare and 2.7 minutes for retrograde (P = .13). The snare group attempts were successful within the 15-minute period in all but one patient (98% success). In the retrograde group, 5 of the 52 (9.6%) crossed over to snare. This difference did not reach statistical significance (P = .11). A difference was seen in the extremes of cannulation times (Table II). The surgeon's experience and graft design were not found to have significant effects on cannulation times. Further analysis of the retrograde group patients with long cannulation times found a relative breakpoint at the 5-minute mark. In those exceeding this time, the chance of success in 15 minutes dropped to 67%. In this group, median time to cannulation was 12.23 minutes for retrograde compared with 7.12 minutes for snare after crossover. Gate cannulation was successful using both methods with no statistical difference between the two in median time. Retrograde was found to be more likely to have short times. If cannulation by retrograde technique had not been achieved in the first 5 minutes, the chances of eventual success dropped significantly and crossover to snare was more efficient. This finding suggests that one should consider an alternative method of gate cannulation if it has not been accomplished within this time.Table IComparison of demographic, anatomic, and procedural factors in snare vs retrograde patientsAll patients (N = 101)Snare (n = 49)Retrograde (n = 52)P valueAge, years75.3 ± 8.074.6 ± 7.575.9 ± 8.4.44Male82 (81.2)38 (77.6)44 (84.6).36BMI28.3 ± 4.928.5 ± 5.328.1 ± 4.5.67Implanting physician years10.7 ± 6.111.0 ± 5.910.5 ± 6.3.69Contralateral gate.31 Left78 (77.2)40 (81.6)38 (73.1) Right23 (22.8)9 (18.4)14 (26.9)Neck angulation10 (0, 22.5)10 (0, 31)10 (0, 20).26Iliac tortuosity.33 Mild44 (43.5)18 (36.7)26 (50.0) Moderate48 (47.5)27 (55.1)21 (40.4) Severe9 (8.9)4 (8.2)5 (9.6)Rotational orientation.34 Anterior92 (91.1)46 (93.9)46 (88.5) Posterior9 (8.9)3 (6.1)6 (11.5)Endograft device.56 Cook Zenith17 (16.8)9 (18.4)8 (15.4) Gore Excluder42 (41.6)21 (42.9)21 (40.4) Medtronic Endurant40 (39.6)19 (38.8)21 (40.4) TriVascular Ovation2 (2.0)0 (0)2 (3.9)Aortic diameter at gate orifice, cm5.0 (4.2, 5.6)4.8 (4.2, 5.5)5.1 (4.5, 5.6).33Distance from aortic bifurcation to gate orifice, cm3.3 (2.1, 4.2)2.9 (2.2, 3.4)3.6 (2.1, 4.5).072Diameter of aortic bifurcation3.2 (2.6, 3.7)3.1 (2.6, 3.5)3.3 (2.8, 3.7).52AO lumen at gate orifice3.2 (2.6, 3.9)2.9 (2.4, 3.5)3.4 (2.9, 4.2).006BMI, Body mass index.Continuous data are presented as mean ± standard deviation or median (25th, 75th percentile), and categorical data are presented as number (%). Open table in a new tab Table IIComparison of cannulation times and overall success in snare vs retrograde gate accessAll patients (N = 101)Snare (n = 49)Retrograde (n = 52)P valueSuccessful cannulation95 (94.1)48 (98.0)47 (90.4).11Cannulation time, minutes3.5 (1.5, 6.1)3.9 (2.2, 6.1)2.7 (1.1, 6.7).13Cannulation <1 minute13 (12.9)2 (4.1)11 (21.2).010Cannulation <2 minutes33 (32.7)11 (22.5)22 (42.3).033Cannulation ≥15 minutes7 (6.9)1 (2.0)6 (11.5).060Fluoroscopy dose, total mGy44 (21, 110)47 (25, 74)43 (15, 187).91Adverse event1 (1.0)0 (0)1 (2.0)1.00Continuous data are presented as median (25th, 75th percentile), and categorical data are presented as number (%). Open table in a new tab
Read full abstract